GETI.B

202.9

+1.3%↑

AMBEA

124.3

+1.14%↑

ARJOB

27.4

+0.96%↑

MSON.B

10.65

-2.29%↓

ORX

26.35

+3.54%↑

GETI.B

202.9

+1.3%↑

AMBEA

124.3

+1.14%↑

ARJOB

27.4

+0.96%↑

MSON.B

10.65

-2.29%↓

ORX

26.35

+3.54%↑

GETI.B

202.9

+1.3%↑

AMBEA

124.3

+1.14%↑

ARJOB

27.4

+0.96%↑

MSON.B

10.65

-2.29%↓

ORX

26.35

+3.54%↑

GETI.B

202.9

+1.3%↑

AMBEA

124.3

+1.14%↑

ARJOB

27.4

+0.96%↑

MSON.B

10.65

-2.29%↓

ORX

26.35

+3.54%↑

GETI.B

202.9

+1.3%↑

AMBEA

124.3

+1.14%↑

ARJOB

27.4

+0.96%↑

MSON.B

10.65

-2.29%↓

ORX

26.35

+3.54%↑

Inicio・Lista de Acciones・Vivesto AB

Vivesto AB

Cerrado

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

Máximo

Métricas clave
By Trading Economics
Ingresos	2.3M -7.2M
BPA	-0.013
Empleados	4
EBITDA	-7.1M

Dividendos
By Dow Jones
Próximas Ganancias	27 feb 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-25M 54M
Apertura anterior	0
Cierre anterior	0

Vivesto AB Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

20 feb 2026, 17:37 UTC

Adquisiciones, fusiones, absorciones

Paramount Regulatory Waiting Period for Warner Bid Expires -- Update

20 feb 2026, 16:18 UTC

Principales Movimientos del Mercado

Footwear Stocks Rise After Supreme Court Strikes Down Tariffs

20 feb 2026, 23:12 UTC

Adquisiciones, fusiones, absorciones

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 feb 2026, 22:12 UTC

Ganancias

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 feb 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

20 feb 2026, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

20 feb 2026, 21:23 UTC

Ganancias

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 feb 2026, 21:20 UTC

Charlas de Mercado

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 feb 2026, 21:01 UTC

Adquisiciones, fusiones, absorciones

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 feb 2026, 20:38 UTC

Charlas de Mercado

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

20 feb 2026, 20:17 UTC

Charlas de Mercado

Oil Futures Mixed As Market Awaits U.S.-Iran Moves -- Market Talk

20 feb 2026, 20:11 UTC

Charlas de Mercado

Traders Await Word on USMCA Exemption For Trump's Global 10% Tariff -- Market Talk

20 feb 2026, 19:59 UTC

Charlas de Mercado

U.S. Tariff Ruling Could Make Things Worse for Mexico -- Market Talk

20 feb 2026, 19:58 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Netflix Seen as Not Needing Warner Bros. Deal -- Market Talk

20 feb 2026, 19:49 UTC

Charlas de Mercado

Mexico's Revised 4Q GDP Expected to Confirm Pick-Up -- Market Talk

20 feb 2026, 19:09 UTC

Charlas de Mercado

Precious Metals Settle Higher After Tariff Ruling -- Market Talk

20 feb 2026, 19:00 UTC

Charlas de Mercado

U.S. Oil, Gas Rig Counts Unchanged on Week -- Market Talk

20 feb 2026, 18:28 UTC

Charlas de Mercado

Ontario Premier Warns Fight Against U.S. Tariffs Isn't Over -- Market Talk

20 feb 2026, 18:20 UTC

Charlas de Mercado

Tariff Ruling Seen Positive for Some Retailers, Mixed for Others -- Market Talk

20 feb 2026, 18:05 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

20 feb 2026, 18:04 UTC

Charlas de Mercado

Trade Uncertainty in Canada to Remain Until USMCA Resolved -- Market Talk

20 feb 2026, 17:38 UTC

Charlas de Mercado

Canada's Small Firms Look Toward Increased U.S. Tariff Opposition -- Market Talk

20 feb 2026, 17:24 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

20 feb 2026, 17:24 UTC

Charlas de Mercado

Correction to Treasury Yields Fall Market Talk

20 feb 2026, 17:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

20 feb 2026, 16:53 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

20 feb 2026, 16:53 UTC

Charlas de Mercado

Canada Dollar Steady, Market Focus on USMCA Review -- Market Talk

20 feb 2026, 16:45 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

20 feb 2026, 16:45 UTC

Charlas de Mercado

U.K. Public Finances Supportive of Gilts in Near-Term -- Market Talk

20 feb 2026, 16:40 UTC

Charlas de Mercado

Trade Threats Facing Canada Not Removed by Supreme Court's Ruling -- Market Talk

Comparación entre iguales

Cambio de precio

Vivesto AB previsión

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Vivesto AB

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.